Ozempic could help overweight people with heart failure, study finds The Independent Compounded semaglutide and tirzepatide vs. Wegovy and Zepbound for weight loss., Wegovy and Zepbound are FDA approved, brand name GLP 1based medications. Compounded semaglutide and compounded CVS Health announced it will remove Zepbound (tirzepatide) from its preferred formulary list starting July 1, 2025, opting instead to prioritize Wegovy (semaglutide). This formulary change reflects broader negotiations between pharmaceutical companies Update! 9 months on Zepbound! Still loving it, but feeling a little stuck. #zepbound